SAMER KABBANI, M.D.
Cardiovascular Disease Physician in EUREKA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SAMER KABBANI, M.D. filed 668 Medicare Part D claims in 2023 as a Cardiovascular Disease Physician in EUREKA, California, prescribing 77% generic.
- 668
- Part D claims, 2023
- 77%
- generic prescribing
- $58.97
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SAMER KABBANI, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
668 Top 31% higher than 69% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
SAMER KABBANI, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SAMER KABBANI, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Cardiovascular Disease Physician compares to other specialties among California providers
Cardiovascular Disease Physician share within California
Cardiovascular Disease Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Cardiovascular Disease Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Cardiovascular Disease Physician ABMS/AOA estimate
Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Cardiovascular Disease Physician US NPIs
Specialty board-certified rate — Cardiovascular Disease Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SAMER KABBANI, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 2332 23RD ST, EUREKA, CA, 95501, with a listed phone of (707) 444-8011. NPI 1851385223 was issued on 08/31/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KABBANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 668 prescription claims written by this provider, covering 288 Medicare beneficiaries and totaling roughly $154K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1851385223 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/31/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SAMER KABBANI, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAMER KABBANI, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$59
Largest payer
SCPHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SAMER KABBANI, M.D.. To verify SAMER KABBANI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
23% brand-name claims vs 77% generic, on 668 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,557
- Total Day Supply
- 46,075
- Brand vs Generic
- 23% brand / 77% generic
- Brand Drug Cost
- $141K
- Generic Drug Cost
- $13K
Patient Demographics
- Average Patient Age
- 74.5 years
- Avg HCC Risk Score
- 1.40
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 21, 65-74: 127, 75-84: 113, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SAMER KABBANI, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
87 claims
- Metoprolol Succinate
Metoprolol Succinate
77 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
59 claims
- Atorvastatin Calcium
Atorvastatin Calcium
37 claims
- Lisinopril 32
Lisinopril
32 claims
- Amlodipine Besylate 31
Amlodipine Besylate
31 claims
- Spironolactone 31
Spironolactone
31 claims
- Amiodarone Hcl 27
Amiodarone Hcl
27 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 87 |
| Metoprolol Succinate | 77 |
| Rosuvastatin Calcium | 59 |
| Atorvastatin Calcium | 37 |
| Lisinopril | 32 |
| Amlodipine Besylate | 31 |
| Spironolactone | 31 |
| Amiodarone Hcl | 27 |
| Clopidogrel Clopidogrel Bisulfate | 27 |
| Entresto Sacubitril/Valsartan | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How SAMER KABBANI, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
SAMER KABBANI, M.D.'s 668 claims are below the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KABBANI.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is SAMER KABBANI, M.D.'s specialty? ▼
How much does SAMER KABBANI, M.D. prescribe under Medicare Part D? ▼
Where is SAMER KABBANI, M.D. located? ▼
What is SAMER KABBANI, M.D.'s NPI number? ▼
Does SAMER KABBANI, M.D. prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does SAMER KABBANI, M.D. prescribe most often? ▼
Does SAMER KABBANI, M.D. accept Medicare? ▼
How can I verify SAMER KABBANI, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology